期刊文献+

基因启动子甲基化对转录因子结合的抑制作用分析方法 被引量:4

Method to Analyze Gene Promoter Methylation Inhibition Effect on Binding of Transcription Factors
下载PDF
导出
摘要 基因启动子甲基化对转录因子结合的抑制作用是一种有效的基因转录调控机制.尽管基因启动子甲基化水平已经可以通过实验测量,但仍未有有效的方法利用这些数据定量分析甲基化对转录因子结合的影响.设计一个通用模型来描述基因启动子甲基化对转录因子结合的抑制作用.在特定细胞环境下,通过基因表达与转录因子在基因启动子上结合值之间的相关性分析,实现模型参数求取,并基于该模型进行甲基化对转录因子结合的抑制作用分析.神经细胞生物实验数据测试证明了该方法的有效性. DNA methylation is identified as an elaborate epigenetic element to regulate binding of transcription factor to gene promoter region. With latest highthroughput technology, it is convenient to accurately test methylation level in experiment, which opens a door to investigate how methylation affects transcription factor. A general model is presented to sense methylation effect on transcription factor in a specific cell. In the model, an inverse sigmoid function is adopted to depict effect of DNA methylation to binding ability of transcription factors with two parameters as center C and steepness S. For each transcription factor, the parameters of model can be fixed by analysis of relativity between transcription factor binding scores in promoter regions and gene expression levels. Here three relativity values should be computed while different formula is used to calculate transcription factor binding score. Relativity value A is obtained when transcription factor binding scores are calculated without considering methylation effect. Relativity value B is analyzed from transcription factor binding scores considering methylation effect with the proposed model. On the contrary, normal sigrnoid function is used to depict effect of DNA methylation and relativity value C is just calculated with transcription factor binding scores considering methylation effect using such model. For a transcription factor, if relativity value B is found obviously larger than relativity value A and relativity value C is always less than relativity value A, the transcription factor can be figured out to be apparently affected by DNA methylation and the model with optimal fixed parameters can be used to depict the methylation effect. In neuroblastoma cell, with the proposed model, 10 transcriptional factors were found to be apparently affected by methylation of promoter regions which proves the effectiveness of the model. Based on the proposed model, TF binding status in genome promoter region can be presumed to further investigate how a gene is regulated by a specific group of TFs organized in a particular pattern, which should be helpful in building of gene regulation network. Moreover, if it is exactly obtained how methylation exerts quite different effect on the same TF between normal and cancer cells, the proposed method also can be used as a way to search mutant TFs which would be responsible for the cancer. But, as so many factors including DNA methylation are involved in gene transcription process and to investigate regulation mechanism of gene transcription is still a hard job.
出处 《生物化学与生物物理进展》 SCIE CAS CSCD 北大核心 2011年第2期177-184,共8页 Progress In Biochemistry and Biophysics
基金 国家自然科学基金(61071174) 国家博士后科学基金(20100471090) 中央高校基本科研业务费专项资金(HEUCF100411)资助项目~~
关键词 基因启动子 转录因子 DNA甲基化 分析方法 gene promoter, transcription factor, DNA methylation, analysis method
  • 相关文献

参考文献15

  • 1Jones P, Takai D. The role of DNA methylation in mammalian epigenetics. Science, 2001, 293(5532): 1068-1070.
  • 2Zilberman D, Gehring M, Tran R K, et al. Genome-wide analysis oi Arabidopsis thaliarm DNA methylation uncovers an interdependence between methylation and transcription. Nature Genetics, 2006, 39(11): 61-69.
  • 3Robertson K. DNA methylation and human disease. Nature Reviews Genetics, 2005, 6(8): 597-610.
  • 4Banelli B, Vinci A, Gelvi I, et al. DNA methylation in neuroblastic tumors. Cancer Letters, 2005, 228(1-2): 37-41.
  • 5Liu J, Morgan M, Hutchison K, et al. A study of the influence of sex on genome wide methylation. PLoS One, 2010, 5(4): 1-8.
  • 6Daniela P, Dennis S, Peter W J R, et al. Interplay between DNA methylation and transcription factor availability: implications for developmental activation of the mouse myogenin gene. Mol Cell Biol, 2010, 30(15): 3805-3815.
  • 7Hertzberg L, Izraeli S, Domany E, et al. STOP: searching for transcription factor motifs using gene expression. Bioinformatics, 2007, 23(14): 1737-1743.
  • 8Guohua W, Yadong W, Weixing F, et al. Transcription factor and microRNA regulation in androgen-dependent and -independent prostate cancer cells. BMC Genomics, 2008, 9(suppl 2): S22.
  • 9Peddada S, Yasui D, LaSalle J, et al. Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome. Human Molecular Genetics, 2006, 15(12): 2003-2014.
  • 10Yasui D, Peddada S, Bieda M, et al. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc Natl Acad Sci USA, 2007, 104 (49): 19416- 19421.

二级参考文献29

  • 1Nakaya T, Cros J, Park MS, et al. Recombinant Newcastle disease virus as a vaccine vector. Virology, 2001, 75(23): 11868-11873.
  • 2Vigil A, Park MS, Garcia-Sastre A, et al. Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus. Cancer Res, 2007, 67(17): 8285-8292.
  • 3Janke M, Peeters B, Schirrmacher V, et al. Recombinant Newcastle disease virus (NDV) with inserted gene coding for GM-CSF as a new vector for cancer immunogene therapy. Gene Ther, 2007, 14(23): 1639-1649.
  • 4Heng Z, Markus J, Volker S, et al. Recombinant Newcastle disease virus expressing human interleukin-2 serves as a potential candidate for tumor therapy. Virus Res, 2008, 136(1/2): 75-80.
  • 5Piihler F, Willuda J, Beier R, et al. Generation of a recombinant oncolytic Newcastle disease virus and expression of a full IgG antibody from two transgenes. Gene Ther, 2008, 15(5): 371 383.
  • 6Vigil A, Martinez O, Garcia-Sastre A, et al. Recombinant Newcastle disease virus as a vaccine vector for cancer therapy. Mol Ther, 2008, 16(11): 1883-1890.
  • 7Zamarin D, Vigil A, Fong Y, et al. Genetically engineered Newcastle disease virus for malignant melanoma therapy. Gene Ther, 2009, 16(6): 796-804.
  • 8Zamarin D, Martinez-Sobrido L, Fong Y, et al. Enhancement of oncolytic properties of recombinant Newcastle disease virus through antagonism of cellular innate immune responses. Mol Ther, 2009, 17(4): 697-706.
  • 9Mayo MA. A summary of taxonomic changes recently approved by ICTV. Arch Virol, 2002, 147(8): 1655-1663.
  • 10DePace NG. Sulla scomparsa di un enorme cancro vegetante del callo dell'utero senza cura chirurgica. Ginecologia, 1912, 9: 82-88.

共引文献4

同被引文献136

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部